Rose v. Brown & Williamson Tobacco Corp.

10 Misc. 3d 680, 234 N.Y.L.J. 81, 2005 NY Slip Op 25459, 809 N.Y.S.2d 784, 2005 N.Y. Misc. LEXIS 2392
CourtNew York Supreme Court
DecidedSeptember 29, 2005
StatusPublished
Cited by4 cases

This text of 10 Misc. 3d 680 (Rose v. Brown & Williamson Tobacco Corp.) is published on Counsel Stack Legal Research, covering New York Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rose v. Brown & Williamson Tobacco Corp., 10 Misc. 3d 680, 234 N.Y.L.J. 81, 2005 NY Slip Op 25459, 809 N.Y.S.2d 784, 2005 N.Y. Misc. LEXIS 2392 (N.Y. Super. Ct. 2005).

Opinion

OPINION OF THE COURT

Karen S. Smith, J.

From February 7, 2005 through March 28, 2005 this court tried the instant case before a jury in three phases. The first phase of the trial was to determine liability for damages suffered by the plaintiffs as a result of plaintiff Norma Rose having smoked cigarettes manufactured by defendants over a 46-year period. The second phase of the trial was to determine if there was sufficient evidence to impose punitive damages on defendants who were found liable in phase one of the trial. Phase three of the trial was to determine what amount, if any, should be imposed as punitive damages on defendants who were found liable for such damages in phase two of the trial.

At the commencement of the trial of this action and throughout the different phases of the trial, the parties made various motions in limine. The court considered the motions, issued [683]*683brief decisions from the bench and advised counsel for the parties that the court would provide written decisions setting forth the court’s reasoning behind its decisions. Because of the importance of this case and in an effort to provide the parties with a clear basis for 'the court’s determinations on their motions, the following are the decisions of this court with respect to the within motions in limine.

Plaintiffs in this action are Norma and Leonard Rose. Norma Rose smoked cigarettes from the time she was a teenager in 1947 up until 1993 when, after repeated efforts, she finally quit. Thereafter, she was diagnosed with lung cancer and perineoplastic cerebella degeneration (PCD). She commenced this litigation against defendant cigarette manufacturers for the damages she alleged to have suffered as a result of smoking their cigarettes. Her husband, Leonard Rose, brought a claim for loss of consortium as a result of his wife’s injuries. By the time the trial commenced, the only remaining cause of action was for negligent product design. The essence of plaintiffs’ cause of action was that defendants’ design of cigarettes with high tar and high nicotine content became negligent at the point in time: (1) defendants knew or should have known that (a) smoking high tar and high nicotine cigarettes increases the risk that a smoker will develop lung cancer, (b) smoking cigarettes is addictive, and (c) consuming less tar and nicotine reduces the risk of developing lung cancer, and (2) it became technologically feasible to make low tar and low nicotine cigarettes.

Plaintiffs Motion to Preclude Common Knowledge Evidence

Plaintiffs’ motion to preclude defendants from introducing evidence at phase one of the trial that the general public has been aware of the dangers of cigarette smoking, from at least 1969, was granted to the extent and for the reasons set forth herein.

Plaintiffs moved to preclude the introduction of evidence of the public’s awareness of the risks of cigarette smoking contending: (1) it was not relevant to the cause of action for negligent product design, and (2) it would be more prejudicial than probative.

Defendants contended that the jury had to be allowed to hear and consider evidence of the public’s awareness of the risks of cigarette smoking as such evidence was one of the factors which the New York State Court of Appeals has established to determine whether a product is not reasonably safe.

[684]*684The first issue to be addressed in a negligent product design case is whether the product in question is defective. A product is defective if it is not reasonably safe. In order to determine whether a product is not reasonably safe, it must be determined if the inherent risks in a product, as designed, outweigh its utility. (Voss v Black & Decker Mfg. Co., 59 NY2d 102, 109 [1983].) To make that determination, the Court of Appeals in Voss considered the following risk/utility factors:

“(1) the utility of the product to the public as a whole and to the individual user; (2) the nature of the product — that is, the likelihood that it will cause injury; (3) the availability of a safer design; (4) the potential for designing and manufacturing the product so that it is safer but remains functional and reasonably priced; (5) the ability of the plaintiff to have avoided injury by careful use of the product; (6) the degree of awareness of the potential danger of the product which reasonably can be attributed to the plaintiff; and (7) the manufacturer’s ability to spread any cost related to improving the safety of the design.” (Id. [citations omitted].)

While Voss was a strict liability case, defendants argued, nevertheless, that “[negligent design and strict products liability claims are treated as ‘functionally equivalent’ by New York courts, and the risk-utility analysis applies to both claims.” (Defendant’s brief regarding the admissibility of awareness evidence on plaintiff’s negligent design claim at 1.) Defendants argued that in the instant case the court is required to charge the jury with all seven factors and allow the jury to determine the relevance and weight of each factor in its deliberations. However, defendants’ argument ignored the precatory language in Voss in which the Court of Appeals stated: “In balancing the risks inherent in the product, as designed, against its utility and cost, the jury may consider several factors. Those factors may include the following” (id. [citations omitted and emphasis added]). More importantly the Court stated: “Pertinent factors in the individual case, when evaluated as to whether or not they are applicable, should form the basis for charging the jury as to how it should evaluate the evidence in order to decide whether a product is not reasonably safe.” (Id. [emphasis added].) In Denny v Ford Motor Co. (87 NY2d 248, 257 [1995]), the Court reiterated its position that such factors are discretionary and tailored to the facts of each case when it stated: “This standard demands inquiry into such factors as.” (Emphasis added.)

[685]*685Although courts have routinely cited Voss and Denny in connection with the risk/utility factors when considering products liability claims, there has been no indication from any court that each factor was intended to be assigned equal weight or that it is mandatory that all seven factors be considered in each and every case. While some cases simply list the seven factors with virtually no discussion or evaluation of the applicability of any given factor to the circumstances of the case (see e.g. Rainbow v Elia Bldg. Co., 79 AD2d 287, 291 [4th Dept 1981]; Jackson v Bomag GmbH, 225 AD2d 879, 881 [3d Dept 1996]), others recognize that there must be consideration of which factors are relevant to the particular case. In Fallon v Hannay & Son (153 AD2d 95, 99 [3d Dept 1989]), the Court made no reference to the seventh factor listed in Voss (the manufacturer’s ability to spread the cost of any safety-related design changes)1 and specifically indicated that it was considering the factors that were “relevant here.” In Scarangella v Thomas Built Buses (93 NY2d 655, 659 [1999]), the Court of Appeals addressed the factors as follows:

“In Voss we identified seven nonexclusive factors to be considered in balancing the risks created by the product’s design against its utility and cost. As relevant here,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pisula v. Roman Catholic Archdiocese of N.Y.
2021 NY Slip Op 06872 (Appellate Division of the Supreme Court of New York, 2021)
Adamo v. Brown & Williamson Tobacco Corp.
900 N.E.2d 966 (New York Court of Appeals, 2008)
Rose v. Brown & Williamson Tobacco Corp.
53 A.D.3d 80 (Appellate Division of the Supreme Court of New York, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
10 Misc. 3d 680, 234 N.Y.L.J. 81, 2005 NY Slip Op 25459, 809 N.Y.S.2d 784, 2005 N.Y. Misc. LEXIS 2392, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rose-v-brown-williamson-tobacco-corp-nysupct-2005.